Be open about drug failures to speed up research
We owe to patients to ensure R&D efforts continue to move forward https://lnkd.in/gDgysUs
We owe to patients to ensure R&D efforts continue to move forward https://lnkd.in/gDgysUs
One of the consequences of Brexit is that EMA will relocate to Amsterdam, the Netherlands, where it has to take up its operations on 30 March 2019 at the latest. EMA is working on the scenario that the UK will become a third country as of 30 March 2019. As a consequence, the UK will …
United Kingdom’s withdrawal from the European Union (‘Brexit’) Read More »
From 18/08/2018 the draft guideline on clinical investigation of medicinal products in the treatment of epileptic disorders – Revision 3 is available for consultation until 17/02/2019. As described by EMA, it should be read in conjunction with other EMA and ICH guidelines. The main changes to the existing guideline include incorporation of the new classification / …